Business news

Growing demand drives flurry of Aussie–Israeli cannabis partnerships

An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.

Chapmans investment in AZ Pharmaceuticals Inc facilitates entry into medicinal cannabis market

Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.

Cannabis Science releases chronic pain transdermal patches

Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.